- This event has passed.
Treatment Considerations in the Age of Fentanyl
April 5 @ 12:00 pm - 1:30 pm
Fentanyl and other high-potency synthetic opioids are increasingly present in the U.S. drug supply. Healthcare systems, treatment providers, and justice systems are grappling with the physiological consequences of chronic fentanyl use and how its use may impact treatment.
Speakers: – Kathryn Cates-Wessel, CEO, American Academy of Addiction Psychiatry – John J. Mariani, MD, Associate Professor of Clinical Psychiatry Division on Substance Use Disorders, Columbia University – Tisha Wiley, PhD, Branch Chief, Associate Director for Justice Systems, NIDA – Jessica Hulsey, Executive Director, Addiction Policy Forum.
Presenters will discuss practical clinical practice-based guidance on treating opioid use disorder in the age of fentanyl, the use of medications for opioid use disorder (MOUD) in the treatment of individuals using fentanyl, and other considerations and challenges. This free webinar is sponsored by the Addiction Policy Forum, the Justice Community Opioid Innovation Network (JCOIN) at the National Institute on Drug Abuse (NIDA), the American Academy of Addiction Psychiatry (AAAP), and the Providers Clinical Support System (PCSS).
This webinar is part of the JCOIN Speaker Series. Led by the National Institute on Drug Abuse (NIDA) and funded by the NIH HEAL Initiative®, JCOIN is a groundbreaking initiative designed to advance scientific knowledge on effective policies, practices, and interventions to address the opioid crisis among justice-involved individuals, by partnering researchers with justice agencies and community health programs.
- April 5
- 12:00 pm - 1:30 pm
- Event Category:
- Other Related
- Addiction Policy Forum
- (301) 769-5966
- « Three years of the COVID-19 Pandemic: What we’ve learned, and how it can make us better at treating rural patients with SUD
- Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Biobehavioral Mechanisms of an Evidence-Based Therapy for Chronic Pain, Opioid Misuse, and Opioid Use Disorder »